Category: Front Page

I told you to watch RCHA.

Do you remember me? = Yes I emailed you a few days ago and I told you to watch RCHA. = This little biotech company has been working on ground breaking drugs and I advised you that you should buy shares in it on Monday morning for around 20 cents….

Continue Reading I told you to watch RCHA.

When was the last time you actually made a few bucks in the market?

when is the last time you actually made a few bucks in the market? With this bull pattern going on it is hard to find a winner that will stand out and actually produce gains that are above average. Not only do I believe that I’ve found a solid company…

Continue Reading When was the last time you actually made a few bucks in the market?

SEO is dead as we know it. – But SPAM is NOT!

Dear Sir/Madam Hope you are doing well, Thank you in advance for taking the time out of your busy day to read and consider this. SEO is dead as we know it. The old math of increased back links and stuffing keywords is now a target for Google to identify…

Continue Reading SEO is dead as we know it. – But SPAM is NOT!

Nuvilex, Inc.’s (NVLX) Expects to Continue Success of Cell-in-a-Box

Nuvilex, Inc.’s (NVLX) Expects to Continue Success of Cell-in-a-Box Technology with Marijuana-Based Treatments If Nuvilex, Inc. (OTCQB: NVLX) can use the Cell-in-a-Box™ technology to develop marijuana-based treatments for cancer with the same success it has seen in two independent clinical trials to develop a treatment for advanced inoperable pancreatic cancer,…

Continue Reading Nuvilex, Inc.’s (NVLX) Expects to Continue Success of Cell-in-a-Box

Nuvilex Announces $27 Million Funding

Nuvilex Inc. (OTCQB: NVLX) Nuvilex Announces $27 Million Funding Commitment With Institutional Investor to Advance Late Phase Clinical Trials Nuvilex, Inc. (NVLX), an international biotechnology company providing cell and gene therapy solutions for the treatment of deadly diseases, announced today that it has entered into a stock purchase agreement with…

Continue Reading Nuvilex Announces $27 Million Funding

Will this SPAM NEVER END!??

Will this SPAM NEVER END!?? Dear Sir/Madam What can PageTraffic do for you? As an award winning digital marketing agency, PageTraffic helps you stay on top of the competition. Our solutions are simple, transparent and are built around your specific requirements. We don’t give complicated or vague estimates and we…

Continue Reading Will this SPAM NEVER END!??

LiveDeal ( Nasdaq: LIVE ) Gives Customers What Groupon and LivingSocial Doesn’t

LiveDeal ( Nasdaq: LIVE ) Gives Customers What Groupon and LivingSocial Doesn’t – Instant Deals LiveDeal, Inc.’s (NASDAQ: LIVE) innovative new platform livedeal.com can operate in a number of verticals, but the company has chosen the $660 billion dining industry to establish their footprint in the Daily Deal space. LIVE’s…

Continue Reading LiveDeal ( Nasdaq: LIVE ) Gives Customers What Groupon and LivingSocial Doesn’t

INSCOR, Inc. (IOGA) designates John Salley as President

INSCOR, Inc. (IOGA) designates John Salley as President of INSCOR’s newly-created sports division Last week, INSCOR Inc., proclaimed that Four-time NBA Champ, Actor, and Humanitarian, John Salley, has been dubbed President of INSCOR’s newly-created sports department and will market INSCOR’s Financed Insurance Trust (FIT) plans to professional athletes and high…

Continue Reading INSCOR, Inc. (IOGA) designates John Salley as President

13/12/2013 20:38 New Monster Pick Alert! Must Read Inside

Is This Bounce for Real? This Company rallied big a few weeks ago, may be starting! Currently traded: 0.0128 Company: Registered Express, Corp Sym: R GTX Date: Fri, December 13, 2013 Is This Bounce for Real? This Company rallied big a few weeks ago, may be starting!

Continue Reading 13/12/2013 20:38 New Monster Pick Alert! Must Read Inside

Plandai Biotechnology, Inc. (PLPL)

Plandai’s Medical Marij. Research Could Advance From FDA Authorization of Clinical Trials Plandai Biotechnology (OTCQB: PLPL) timed its move into medical marij research perfectly. In Nov. the FDA approved clinical trials of the cannabis-based drug, Epidolex, and its impacts on epilepsy. This approval is a milestone decision by the FDA…

Continue Reading Plandai Biotechnology, Inc. (PLPL)